Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert CofiledCriticalWarner Lambert Co
Priority to DO2003000602ApriorityCriticalpatent/DOP2003000602A/en
Publication of DOP2003000602ApublicationCriticalpatent/DOP2003000602A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Esta invención describe compuestos que alteran la actividad de PPAR. La invención tambien describe sales farmaceuticamente aceptables de los compuestos, composiciones farmaceuticamente aceptables que comprenden los compuestos o sus sales, y metodos para utilizarlas como agentes terapeuticos para tratar o prevenir hiperlipidemia e hipercolesteremia en un mamifero. La presente invención tambien describe un metodo para obtener los compuestos descritos.This invention describes compounds that alter the activity of PPAR. The invention also describes pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable compositions comprising the compounds or their salts, and methods for use as therapeutic agents to treat or prevent hyperlipidemia and hypercholesterolemia in a mammal. The present invention also describes a method for obtaining the described compounds.
DO2003000602A2003-03-062003-03-06
COMPOUNDS THAT MODULATE THE ACTIVITY OF PPAR
DOP2003000602A
(en)